Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.
Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Donor-Derived iPS Cells Show Promise for Treating Eye Disease

Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.

Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.

stem cell trials
Texas Stem Cell Law Opens Door for Controversial Treatments
Texas Stem Cell Law Opens Door for Controversial Treatments
Anna Azvolinsky | Mar 27, 2018
The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.
CIRM Ups Translational Velocity
CIRM Ups Translational Velocity
Bob Grant | Dec 20, 2015
California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.
Hearts on Trial
Hearts on Trial
Kerry Grens | May 1, 2015
As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.
Heart Strings
Heart Strings
The Scientist Staff | Apr 30, 2015
An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients
Stem Cell Trial for Eye Disease Commences
Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Done with Immunosuppressants
Done with Immunosuppressants
Jef Akst | Jul 3, 2014
Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.
Geron hESC Trial to Resume?
Geron hESC Trial to Resume?
Jef Akst | May 27, 2014
Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.
More Evidence of Stem Cell Errors
More Evidence of Stem Cell Errors
Kerry Grens | Feb 25, 2014
A committee at the University of Düsseldorf finds misconduct in cardiologist Bodo-Eckehard Strauer’s work.  
Stem-Cell Clinic Moves to Mexico
Stem-Cell Clinic Moves to Mexico
Dan Cossins | Feb 1, 2013
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.